サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1140349

コネクテッドドラッグデリバリーデバイス市場：タイプ別（注射器、吸入器）、技術別（Bluetooth、NFC、その他）、エンドユーザー別（ホームケア、病院） - 世界の機会分析および産業予測、2021-2030年

Connected Drug Delivery Devices Market By Type (Injectable, Inhalation Devices), By Technology (Bluetooth, NFC, Others), By End-use (Homecare, Hospitals): Global Opportunity Analysis and Industry Forecast, 2021-2030
出版日: | 発行: Allied Market Research | ページ情報: 英文 210 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
コネクテッドドラッグデリバリーデバイス市場：タイプ別（注射器、吸入器）、技術別（Bluetooth、NFC、その他）、エンドユーザー別（ホームケア、病院） - 世界の機会分析および産業予測、2021-2030年
出版日: 2022年08月01日
発行: Allied Market Research
ページ情報: 英文 210 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

コネクテッドドラッグデリバリーデバイスの世界市場は、2021年の2億9,030万米ドルから2022年から2030年にかけてCAGR24.29％で成長し、2030年までに20億9,520万米ドルを獲得すると想定されます。

コネクテッドドラッグデリバリーデバイスは、さまざまなデジタルサービスへの接続を含む機能が統合されています。これらのデバイスは、優れた患者の監視とカウンセリングをサポートすることを目的として、さまざまな市場参加者によって開発されています。接続型ドラッグデリバリーデバイスには、健康情報を収集するためのアドヒアランス・トラッカー、投与残量、患者ダイアリーなどの機能が搭載されています。これらのデバイスは、喘息、慢性閉塞性肺疾患（COPD）、糖尿病、その他の心血管疾患の治療で顕著に使用されています。

治療手順におけるドラッグデリバリーデバイスの効率性と電子ヘルスケア機器の使用率の上昇により、予測期間中、接続型ドラッグデリバリーデバイスの市場拡大が促進されると予想されます。これに加えて、糖尿病、COPD、喘息の有病率の増加は、予測期間中、接続型ドラッグデリバリーデバイスの使用増加のための有利な可能性を提供すると予測されます。

一方、研究開発の熟練度、限られたインフラ施設、ドラッグデリバリーシステムに対する厳しい規制の賦課に関連する高コストが、市場成長の妨げになると予測されます。また、新興経済諸国における有利な償還シナリオや技術の浸透の欠如、低コストの代替品の入手可能性、低・中所得国における適切なインフラの欠如などが、予測期間中の市場の課題として予測されています。

さらに、ターゲットを絞った研究イニシアティブに対する官民の資金提供の増加、大気汚染レベルの上昇、世界の技術的躍進による製品の革新と開発の増加はすべて、予測期間を通じて市場の主要プレイヤーに有利な機会を生み出すでしょう。将来的には、戦略的提携の拡大、インターネット利用の増加、病院や研究所の増加、医療費に対する一人当たりの支出の増加などにより、市場の成長率は加速されると考えられます。例えば、ドラッグデリバリーシステムの世界的リーダーであるAptar Pharmaは、2022年2月、患者の吸入技術やアドヒアランスに対応した次世代型定量吸入器（MDI）アドオン接続デバイスである製品Hero Tracker Senseを発表しました。喘息、COPD、嚢胞性線維症などの慢性呼吸器疾患に苦しむ世界中の患者の生活を改善し、MDIの使用状況を把握し、処方された治療のアドヒアランス向上を促進するために設計されたもので、COVID-19に起因します。

COVID-19の大流行による世界の流通・販売チャネルの混乱が、接続型ドラッグデリバリーデバイスの売上減少の原因になっている可能性があります。人々は、監禁、社会的疎外などの制限に直面しなければなりませんでした。パンデミック時には、生産、在庫管理、商品・サービスの流通などのビジネスプロセスが停止し、世界経済に大きな影響を与えることが予想されます。しかし、コロナウイルスの発生により、簡単で安全な在宅療養設定用医療機器の需要が高くなりました。また、医療従事者は、オンライン接続機器の必要性から、患者の薬を遠隔でモニターすることができるようになりました。これらの要因により、COVID-19の大流行による悪影響は軽減され、市場は徐々に拡大し続けました。

コネクテッドドラッグデリバリーデバイス市場のレポートで紹介されている主要企業は、Adherium、BD、Proteus Digital Health、propeller Health、F. Hoffmann-La Roche Ltd、Ypsomed AG、Cohero Health, Inc、West Pharmaceutical Services、Syncro Technology Corp、AptarGroup Inc.等です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析
  • 規制ガイドライン
  • バリューチェーン分析
  • 市場シェア分析
  • 主要規制の分析
  • 特許情勢

第4章 コネクテッドドラッグデリバリーデバイス市場：タイプ別

  • 概要
    • 市場規模・予測
  • 注射器
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 吸入デバイス
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第5章 コネクテッドドラッグデリバリーデバイス市場：技術別

  • 概要
    • 市場規模・予測
  • ブルートゥース
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別分析
  • NFC
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第6章 コネクテッドドラッグデリバリーデバイス市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • ホームケア
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 病院
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第7章 コネクテッドドラッグデリバリーデバイス市場： 地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米の市場規模・予測：タイプ別
    • 北米市場規模・予測：技術別
    • 北米市場規模・予測：エンドユーザー別
    • 北米市場規模・予測：国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州の市場規模・予測：タイプ別
    • 欧州市場規模・予測：技術別
    • 欧州市場規模・予測：エンドユーザー別
    • 欧州市場規模・予測：国別
      • ドイツ
      • 英国
      • フランス
      • スペイン
      • イタリア
      • その他の欧州地域
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測：タイプ別
    • アジア太平洋地域の市場規模・予測：技術別
    • アジア太平洋地域の市場規模・予測：エンドユーザー別
    • アジア太平洋地域の市場規模・予測：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • オーストラリア
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測：タイプ別
    • LAMEAの市場規模・予測：技術別
    • LAMEAの市場規模・予測：エンドユーザー別
    • LAMEAの市場規模・予測：国別
      • ブラジル
      • サウジアラビア
      • UAE
      • 南アフリカ共和国
      • LAMEAの残りの地域

第8章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第9章 企業プロファイル

  • Adherium
  • BD
  • Proteus Digital Health
  • PROPELLER HEALTH
  • F. Hoffmann-La Roche Ltd
  • Ypsomed AG
  • Cohero Health, Inc.
  • West Pharmaceutical Services, Inc.
  • Syncro Technology Corp.
  • AptarGroup Inc.
図表

LIST OF TABLES

  • TABLE 1. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 2. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR INJECTABLE, BY REGION, 2021-2030 ($MILLION)
  • TABLE 3. CONNECTED DRUG DELIVERY DEVICES MARKET FOR INJECTABLE, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 4. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR INHALATION DEVICES, BY REGION, 2021-2030 ($MILLION)
  • TABLE 5. CONNECTED DRUG DELIVERY DEVICES MARKET FOR INHALATION DEVICES, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 7. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR BLUETOOTH, BY REGION, 2021-2030 ($MILLION)
  • TABLE 8. CONNECTED DRUG DELIVERY DEVICES MARKET FOR BLUETOOTH, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 9. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR NFC, BY REGION, 2021-2030 ($MILLION)
  • TABLE 10. CONNECTED DRUG DELIVERY DEVICES MARKET FOR NFC, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 11. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR OTHERS, BY REGION, 2021-2030 ($MILLION)
  • TABLE 12. CONNECTED DRUG DELIVERY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 14. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR HOMECARE, BY REGION, 2021-2030 ($MILLION)
  • TABLE 15. CONNECTED DRUG DELIVERY DEVICES MARKET FOR HOMECARE, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 16. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2030 ($MILLION)
  • TABLE 17. CONNECTED DRUG DELIVERY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 18. CONNECTED DRUG DELIVERY DEVICES MARKET, BY REGION, 2021-2030 ($MILLION)
  • TABLE 19. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 20. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 21. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 22. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 23. U.S. CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 24. U.S. CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 25. U.S. CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 26. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 27. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 28. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 29. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 30. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 31. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 32. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 33. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 34. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 35. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 36. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 37. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 38. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 39. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 40. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 41. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 42. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 43. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 44. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 45. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 46. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 47. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 48. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 49. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 50. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 51. REST OF EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 52. REST OF EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 53. REST OF EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 54. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 55. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 56. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 57. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 58. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 59. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 60. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 61. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 62. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 63. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 64. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 65. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 66. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 67. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 68. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 69. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 70. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 71. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 72. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 73. REST OF ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 74. REST OF ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 75. REST OF ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 76. LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 77. LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 78. LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 79. LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 80. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 81. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 82. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 83. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 84. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 85. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 86. UAE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 87. UAE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 88. UAE CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 89. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 90. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 91. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 92. REST OF LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 93. REST OF LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 94. REST OF LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 95.ADHERIUM: COMPANY SNAPSHOT
  • TABLE 96.ADHERIUM: OPERATING SEGMENTS
  • TABLE 97.ADHERIUM: PRODUCT PORTFOLIO
  • TABLE 98.ADHERIUM: NET SALES,
  • TABLE 99.ADHERIUM: KEY STRATERGIES
  • TABLE 100.BD: COMPANY SNAPSHOT
  • TABLE 101.BD: OPERATING SEGMENTS
  • TABLE 102.BD: PRODUCT PORTFOLIO
  • TABLE 103.BD: NET SALES,
  • TABLE 104.BD: KEY STRATERGIES
  • TABLE 105.PROTEUS DIGITAL HEALTH: COMPANY SNAPSHOT
  • TABLE 106.PROTEUS DIGITAL HEALTH: OPERATING SEGMENTS
  • TABLE 107.PROTEUS DIGITAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 108.PROTEUS DIGITAL HEALTH: NET SALES,
  • TABLE 109.PROTEUS DIGITAL HEALTH: KEY STRATERGIES
  • TABLE 110.PROPELLER HEALTH: COMPANY SNAPSHOT
  • TABLE 111.PROPELLER HEALTH: OPERATING SEGMENTS
  • TABLE 112.PROPELLER HEALTH: PRODUCT PORTFOLIO
  • TABLE 113.PROPELLER HEALTH: NET SALES,
  • TABLE 114.PROPELLER HEALTH: KEY STRATERGIES
  • TABLE 115.F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
  • TABLE 116.F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
  • TABLE 117.F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
  • TABLE 118.F. HOFFMANN-LA ROCHE LTD: NET SALES,
  • TABLE 119.F. HOFFMANN-LA ROCHE LTD: KEY STRATERGIES
  • TABLE 120.YPSOMED AG: COMPANY SNAPSHOT
  • TABLE 121.YPSOMED AG: OPERATING SEGMENTS
  • TABLE 122.YPSOMED AG: PRODUCT PORTFOLIO
  • TABLE 123.YPSOMED AG: NET SALES,
  • TABLE 124.YPSOMED AG: KEY STRATERGIES
  • TABLE 125.COHERO HEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 126.COHERO HEALTH, INC.: OPERATING SEGMENTS
  • TABLE 127.COHERO HEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 128.COHERO HEALTH, INC.: NET SALES,
  • TABLE 129.COHERO HEALTH, INC.: KEY STRATERGIES
  • TABLE 130.WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
  • TABLE 131.WEST PHARMACEUTICAL SERVICES, INC.: OPERATING SEGMENTS
  • TABLE 132.WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT PORTFOLIO
  • TABLE 133.WEST PHARMACEUTICAL SERVICES, INC.: NET SALES,
  • TABLE 134.WEST PHARMACEUTICAL SERVICES, INC.: KEY STRATERGIES
  • TABLE 135.SYNCRO TECHNOLOGY CORP.: COMPANY SNAPSHOT
  • TABLE 136.SYNCRO TECHNOLOGY CORP.: OPERATING SEGMENTS
  • TABLE 137.SYNCRO TECHNOLOGY CORP.: PRODUCT PORTFOLIO
  • TABLE 138.SYNCRO TECHNOLOGY CORP.: NET SALES,
  • TABLE 139.SYNCRO TECHNOLOGY CORP.: KEY STRATERGIES
  • TABLE 140.APTARGROUP INC.: COMPANY SNAPSHOT
  • TABLE 141.APTARGROUP INC.: OPERATING SEGMENTS
  • TABLE 142.APTARGROUP INC.: PRODUCT PORTFOLIO
  • TABLE 143.APTARGROUP INC.: NET SALES,
  • TABLE 144.APTARGROUP INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.CONNECTED DRUG DELIVERY DEVICES MARKET SEGMENTATION
  • FIGURE 2.CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030
  • FIGURE 3.CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.CONNECTED DRUG DELIVERY DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.REGULATORY GUIDELINES
  • FIGURE 13.VALUE CHAIN ANALYSIS
  • FIGURE 14.MARKET SHARE ANALYSIS
  • FIGURE 15.KEY REGULATION ANALYSIS
  • FIGURE 16.PATENT ANALYSIS BY COMPANY
  • FIGURE 17.PATENT ANALYSIS BY COUNTRY
  • FIGURE 18.CONNECTED DRUG DELIVERY DEVICES MARKET,BY TYPE,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF INJECTABLE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF INHALATION DEVICES CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 21.CONNECTED DRUG DELIVERY DEVICES MARKET,BY TECHNOLOGY,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF BLUETOOTH CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF NFC CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 25.CONNECTED DRUG DELIVERY DEVICES MARKET,BY END-USE,2021(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF HOMECARE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HOSPITALS CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 28.CONNECTED DRUG DELIVERY DEVICES MARKET BY REGION,2021
  • FIGURE 29.U.S. CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 30.CANADA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 31.MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 32.GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 33.UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 34.FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 35.SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 36.ITALY CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 37.REST OF EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 38.CHINA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 39.JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 40.INDIA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 41.SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 42.AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 43.REST OF ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 44.BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 45.SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 46.UAE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 47.SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 48.REST OF LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 49. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 52.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 53.COMPETITIVE DASHBOARD
  • FIGURE 54.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 55.ADHERIUM.: NET SALES ,($MILLION)
  • FIGURE 56.BD.: NET SALES ,($MILLION)
  • FIGURE 57.PROTEUS DIGITAL HEALTH.: NET SALES ,($MILLION)
  • FIGURE 58.PROPELLER HEALTH.: NET SALES ,($MILLION)
  • FIGURE 59.F. HOFFMANN-LA ROCHE LTD.: NET SALES ,($MILLION)
  • FIGURE 60.YPSOMED AG.: NET SALES ,($MILLION)
  • FIGURE 61.COHERO HEALTH, INC..: NET SALES ,($MILLION)
  • FIGURE 62.WEST PHARMACEUTICAL SERVICES, INC..: NET SALES ,($MILLION)
  • FIGURE 63.SYNCRO TECHNOLOGY CORP..: NET SALES ,($MILLION)
  • FIGURE 64.APTARGROUP INC..: NET SALES ,($MILLION)
目次
Product Code: A26017

The global connected drug delivery devices market is envisioned to garner $2,095.2 million by 2030, growing from $290.3 million in 2021 at a CAGR of 24.29% from 2022 to 2030.

Connected drug delivery devices are integrated with capabilities that include connectivity to a wide range of digital services. These devices are being developed by various market players with an aim to support superior patient supervision and counselling. Connected drug delivery devices are equipped with several features, such as adherence trackers, dosing remainders, and patient diaries to collect health information. These devices are prominently used in the treatment of asthma, Chronic Obstructive Pulmonary Disease (COPD), diabetes, and other cardiovascular disorders.

The efficiency of drug delivery devices in therapeutic procedures along with rising usage of electronic healthcare devices are anticipated to fuel market expansion for connected drug delivery devices over the forecast period. In addition to this, it is projected that an increase in the prevalence of diabetes, COPD, and asthma will offer a lucrative potential for increasing use of connected drug delivery devices throughout the course of the forecast period.

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, and imposition of stringent regulations on drug delivery systems are expected to hinder the market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, availability of low-cost substitutes, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period.

Furthermore, increased public-private funding for targeted research initiatives, rising air pollution levels, and an increase in product innovations and development due to global technological breakthroughs will all create lucrative opportunities for key players in the market throughout the projection period. In the future, the market growth rate will be accelerated due to expanding number of strategic alliances, increasing Internet usage, increasing number of hospitals and laboratories, and rising per-capita expenditure on health care spending. For instance, in February 2022, Aptar Pharma, a global leader in drug delivery systems launched a product Hero Tracker Sense, which is a next generation Metered-Dose Inhaler (MDI) add-on connected device, designed to address patient inhalation technique and adherence. It is designed to help improve the lives of patients around the world suffering from chronic respiratory diseases such as asthma, COPD, cystic fibrosis, and other respiratory conditions caused by COVID-19, to track their MDI usage and facilitate improved adherence to their prescribed therapy.

Global distribution and sales channel disruption due to COVID-19 pandemic could be blamed for the decline in connected drug delivery devices sales. People had to face restrictions such as lockdown, social distancing, and others. During the pandemic, business processes such as production, inventory management, and distribution of goods and services have ceased, which is expected to have a significant impact on the worldwide economy. However, the coronavirus outbreak made the high demand for simple and secure homecare setting medical devices. A healthcare provider is now able to remotely monitor a patient's medicine due to the requirement for online connectivity equipment. Owing to these factors, the COVID-19 pandemic's negative effects were decreased and the market kept expanding gradually.

The key players profiled in the connected drug delivery devices market report include Adherium, BD, Proteus Digital Health, propeller Health, F. Hoffmann-La Roche Ltd, Ypsomed AG, Cohero Health, Inc., West Pharmaceutical Services, Syncro Technology Corp., and AptarGroup Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the connected drug delivery devices market analysis from 2021 to 2030 to identify the prevailing connected drug delivery devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the connected drug delivery devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global connected drug delivery devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Injectable Devices
  • Inhalation Devices
  • Others

By Technology

  • NFC
  • Bluetooth
  • Others
  •  By End-user
  • Homecare settings
  • Hospitals

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • United Arab Emirates
  • South Africa
  • Rest of LAMEA
  • List of Key Players Profiled in the Report
  • Adherium
  • BD
  • Proteus Digital Health
  • propeller Health
  • F. Hoffmann-La Roche Ltd
  • Ypsomed AG
  • Cohero Health, Inc.
  • West Pharmaceutical Services, Inc.
  • Syncro Technology Corp. 
  • AptarGroup Inc.
  • Key Market Segments

By Type

  • Injectable
  • Inhalation Devices

By Technology

  • Bluetooth
  • NFC
  • Others

By End-use

  • Homecare
  • Hospitals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest Of Asia Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Adherium
    • BD
    • Proteus Digital Health
    • PROPELLER HEALTH
    • F. Hoffmann-La Roche Ltd
    • Ypsomed AG
    • Cohero Health, Inc.
    • West Pharmaceutical Services, Inc.
    • Syncro Technology Corp.
    • AptarGroup Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Regulatory Guidelines
  • 3.8.Value Chain Analysis
  • 3.9.Market Share Analysis
  • 3.10.Key Regulation Analysis
  • 3.11.Patent Landscape

CHAPTER 4: CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Injectable
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Inhalation Devices
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Bluetooth
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 NFC
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Others
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Homecare
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Hospitals
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country

CHAPTER 7: CONNECTED DRUG DELIVERY DEVICES MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Technology
    • 7.2.4 North America Market size and forecast, by End-use
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Technology
      • 7.2.5.1.3 Market size and forecast, by End-use
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Technology
      • 7.2.5.2.3 Market size and forecast, by End-use
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Technology
      • 7.2.5.3.3 Market size and forecast, by End-use
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Technology
    • 7.3.4 Europe Market size and forecast, by End-use
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Technology
      • 7.3.5.1.3 Market size and forecast, by End-use
      • 7.3.5.2 United Kingdom
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Technology
      • 7.3.5.2.3 Market size and forecast, by End-use
      • 7.3.5.3 France
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Technology
      • 7.3.5.3.3 Market size and forecast, by End-use
      • 7.3.5.4 Spain
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Technology
      • 7.3.5.4.3 Market size and forecast, by End-use
      • 7.3.5.5 Italy
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Technology
      • 7.3.5.5.3 Market size and forecast, by End-use
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Technology
      • 7.3.5.6.3 Market size and forecast, by End-use
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Technology
    • 7.4.4 Asia-Pacific Market size and forecast, by End-use
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Technology
      • 7.4.5.1.3 Market size and forecast, by End-use
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Technology
      • 7.4.5.2.3 Market size and forecast, by End-use
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Technology
      • 7.4.5.3.3 Market size and forecast, by End-use
      • 7.4.5.4 South Korea
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Technology
      • 7.4.5.4.3 Market size and forecast, by End-use
      • 7.4.5.5 Australia
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Technology
      • 7.4.5.5.3 Market size and forecast, by End-use
      • 7.4.5.6 Rest Of Asia Pacific
      • 7.4.5.6.1 Market size and forecast, by Type
      • 7.4.5.6.2 Market size and forecast, by Technology
      • 7.4.5.6.3 Market size and forecast, by End-use
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Technology
    • 7.5.4 LAMEA Market size and forecast, by End-use
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Technology
      • 7.5.5.1.3 Market size and forecast, by End-use
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Technology
      • 7.5.5.2.3 Market size and forecast, by End-use
      • 7.5.5.3 UAE
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Technology
      • 7.5.5.3.3 Market size and forecast, by End-use
      • 7.5.5.4 South Africa
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Technology
      • 7.5.5.4.3 Market size and forecast, by End-use
      • 7.5.5.5 Rest of LAMEA
      • 7.5.5.5.1 Market size and forecast, by Type
      • 7.5.5.5.2 Market size and forecast, by Technology
      • 7.5.5.5.3 Market size and forecast, by End-use

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Adherium
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 BD
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Proteus Digital Health
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 PROPELLER HEALTH
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 F. Hoffmann-La Roche Ltd
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Ypsomed AG
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Cohero Health, Inc.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 West Pharmaceutical Services, Inc.
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Syncro Technology Corp.
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 AptarGroup Inc.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments